Lisa Catalli, MSN, NP-C

University of California San Francisco

Post-Liver Transplant BRIDGE to Liver Health Program

Jessica Fisher, DNP, APRN, NP-C

University of Minnesota

Timed Measurements of Plasma Iohexol Clearance and Accuracy of Donor mGFR

*ASTS gratefully acknowledges Veloxis as our funding partner for this award

Lindsay Powell, MSN, ACNP-AG, FNP-C

Duke University

Transplant Advanced Practice Provider Burnout Survey (TABS)

Christine Trotter, MSN, RN, CCRN, ACNP

Edward Hines, Jr. VA Medical Center

Cytomegalovirus (CMV) infection incidence in an elderly population following changes to immunosuppression induction and management

*Sponsored by Dr. Nancy Ascher and Dr. John Roberts

Ashton Connor, MD, PhD, FRCSC

Houston Methodist Hospital

Liver Transplant Oncology Program for Cholangiocarcinoma: A Precision Medicine Strategy for Improving Outcomes

Siavash Raigani, MD

Massachusetts General Surgery

Disequilibrium between autophagy and apoptosis as a therapeutic target for rehabilitation of marginal livers using normothermic machine perfusion

Ryutaro Hirose, MD

University of California San Francisco

Identifying Predictors and Risk Factors of Liver Transplant Referral Outcome

Andrew Barbas, MD

Duke University

Engineering Strategies for Replenishable, Drug-Eluting Transplants

Tatiana Segura, PhD

 Duke University

Engineering Strategies for Replenishable, Drug-Eluting Transplants

Simon Chu, MD

University of California San Francisco

Improving the Safety of Stem-cell-derived Beta Cell Transplantation with Inducible Safety Switches

Joseph Ladowski, MD, PhD

Duke University

Genetic engineering of the SLA as a method to modulate xenogeneic T cell proliferation

Isaac Alderete

Duke University School of Medicine

Liproxstatin-2 As a Therapeutic to Mitigate Renal Ischemia-Reperfusion Injury in a Murine Model

* Sponsored by Dr. Elizabeth Pomfret and Dr. Jim Pomposelli

Shakhzoda Alimdjanova

Rutgers New Jersey Medical School

Longitudinal Analysis of Persistent Immune Dysfunction as a Predictor of Outcomes in Patients Following Liver Transplant

*Sponsored by Dr. Jayme Locke

Sydney Castellanos

Ohio State University College of Medicine

Investigating the effector function and antigen specificity of anti-viral and antibody-suppressor CXCR5+CD8+ T cell subsets

*Sponsored by Dr. Deb Sudan

Austin Eason

University of Florida College of Medicine

Improving the efficacy of human primary hepatocyte transplantation: Implementation of a novel 3D peptide hydrogel

*Sponsored by Dr. Peter Stock

Erin Foster

University of Maryland School of Medicine

Exploring the Impact of Persistent Hyperparathyroidism with Normocalcemia on Kidney Allograft Functions, Survival and Bone Health in Renal Transplant Patients

*Sponsored by Dr. and Mrs. Charlie and Erika Miller

Sydney Jeffs

Duke University School of Medicine

Novel Chemical Strategies for Replenishable, Drug-Eluting Transplants

Mariah Jordan

University of Florida College of Medicine

Modeling the Molecular Pathways of the Hispanic NAFLD/NASH Disparity in Human Precision Cut Liver Slices

*Sponsored by Dr. Linda Cendales

Hayoung Kim

Keck School of Medicine of University of Southern California

Creation of a liquid biopsy to predict outcomes in pediatric acute liver failure

*Sponsored by ASTS Members

Allison Schwalb

Duke University School of Medicine

Evaluation of Cardiac Allograft Vasculopathy Following ONX-0914-mediated Immunoproteasome Inhibition in a Sensitized Murine Cardiac Allotransplant Model

*Sponsored by Dr. Sommer Gentry and Dr. Dorry Segev

Yash Shah

Rutgers New Jersey Medical School

Evaluation of Severe Pre-Transplant Immune Dysfunction as a Risk Factor of Recurrence of Hepatocellular Carcinoma (HCC) after Liver Transplant